Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Sponsor: National Jewish Health
Summary
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Official title: Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
137
Start Date
2021-01-06
Completion Date
2026-07-31
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Locations (7)
University of Arizona
Tucson, Arizona, United States
University of California Davis
Sacramento, California, United States
National Jewish Health
Denver, Colorado, United States
University of Chicago
Chicago, Illinois, United States
Mayo Clinic
Rochester, Minnesota, United States
University of Texas Southwestern
Dallas, Texas, United States
University of Utah
Salt Lake City, Utah, United States